Bio-Rad Laboratories Class BBIO.B
13F holders, Q2 2024 (June 30)8holders +1
1new positions
0sold out
$271.44avg. 13F price*
At the end of Q2 2024, 8 institutions reported holding Bio-Rad Laboratories Class B (BIO.B) in their 13F filings, up 1 from Q1 2024. 1 opened new positions and 0 sold out. The largest holders were CSS LLC ($439K), Buckingham Strategic Wealth, LLC ($203K) and Morgan Stanley ($190K).
- Company
- Bio-Rad Laboratories Class B
- CUSIP
- 090572108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $341 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 1 shares bought and 212 shares sold, net −211 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| CSS LLC | 0.10% | Reduce -11.1% | 1,607 | $439K |
| Buckingham Strategic Wealth, LLC | 0.00% | No change | 760 | $203K |
| Morgan Stanley | 0.00% | Reduce -1.7% | 712 | $190K |
| Wells Fargo & Company | 0.00% | No change | 170 | $48K |
| Whittier Trust Co. | 0.00% | No change | 160 | $45K |
| Jones Financial Companies LLLP | 0.00% | No change | 33 | $9K |
| JNBA Financial Advisors | 0.00% | No change | 2 | $534 |
| Mather Group, Llc. | 0.00% | New | 1 | $341 |
"% of holder's portfolio" is BIO.B's weight in each manager's 13F, not the share of Bio-Rad Laboratories Class B the manager owns.